Low risk of recurrence following artesunate–Sulphadoxine–pyrimethamine plus primaquine for uncomplicated Plasmodium falciparum and Plasmodium vivax infections in the Republic of the Sudan

BACKGROUND: First-line schizontocidal treatment for uncomplicated malaria in the Republic of the Sudan is artesunate (total dose 12 mg/kg) plus Sulphadoxine/pyrimethamine (25/1.25 mg/kg) (AS/SP). Patients with Plasmodium vivax are also treated with 14 days primaquine (total dose 3.5 mg/kg) (PQ). The...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Malar J
Main Authors: Hamid, Muzamil Mahdi Abdel, Thriemer, Kamala, Elobied, Maha E., Mahgoub, Nouh S., Boshara, Salah A., Elsafi, Hassan M. H., Gumaa, Suhaib A., Hamid, Tassneem, Abdelbagi, Hanadi, Basheir, Hamid M., Marfurt, Jutta, Chen, Ingrid, Gosling, Roly, Price, Ric N., Ley, Benedikt
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5857106/
https://ncbi.nlm.nih.gov/pubmed/29548285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12936-018-2266-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados